Invention Grant
- Patent Title: Derivatisation of erythropoietin (EPO)
-
Application No.: US14313888Application Date: 2014-06-24
-
Publication No.: US09266936B2Publication Date: 2016-02-23
- Inventor: Sanjay Jain , Peter Laing , Gregory Gregoriadis , Norbert Oskar Rumpf
- Applicant: Lipoxen Technologies Limited
- Applicant Address: GB London
- Assignee: Lipoxen Technologies Limited
- Current Assignee: Lipoxen Technologies Limited
- Current Assignee Address: GB London
- Agency: One3 IP Management, P.C.
- Agent Dean G. Stathakis; Peter D. Weinstein
- Priority: EP06117830 20060725
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/18 ; C07K14/535 ; A61K47/48 ; C07K14/52 ; C07K14/505 ; C07K14/575 ; A61K38/46 ; A61K38/19
Abstract:
The present invention relates to a compound which is a polysaccharide derivative of EPO, or of an EPO like protein, wherein the polysaccharide is anionic and comprises between 2 and 200 saccharide units. The present invention also relates to pharmaceutical compositions comprising the novel compounds, and methods for making the novel compounds.
Public/Granted literature
- US20140309166A1 Derivatisation of Erythropoietin (EPO) Public/Granted day:2014-10-16
Information query
IPC分类:
